Finance

Beta
Lists
330350:KOSDAQ
Withus Pharmaceutical Co Ltd
၆,၇၆၀.၀၀ ₩
-၂.၇၃%
(-၁၉၀.၀၀) 1D
ဇွန် ၁, GMT+၉ ၁၅:၃၀:၃၀  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 330350...
Open
၆,၉၅၀ ₩
High
၆,၉၅၀ ₩
Low
၆,၆၇၀ ₩
Mkt. cap
ဋေ ၈.၉၂ ထ
Avg. vol.
၉.၆၀ သောင်း
Volume
၆.၆၉ သောင်း
P/E ratio
၁၂.၂၄
52-wk high
၁၁,၉၅၀ ₩
52-wk low
၆,၂၀၀ ₩
EPS
၅၅၂ ₩
Shares outstanding
၁.၃၂ ကုဋေ
No. of employees
၂၂၃
Open
၆,၉၅၀ ₩
High
၆,၉၅၀ ₩
Low
၆,၆၇၀ ₩
Mkt. cap
ဋေ ၈.၉၂ ထ
Avg. vol.
၉.၆၀ သောင်း
Volume
၆.၆၉ သောင်း
P/E ratio
၁၂.၂၄
52-wk high
၁၁,၉၅၀ ₩
52-wk low
၆,၂၀၀ ₩
EPS
၅၅၂ ₩
Shares outstanding
၁.၃၂ ကုဋေ
No. of employees
၂၂၃
News stories
From sources across the web
Brownstone Research
Brownstone Research
·
ပြီးခဲ့သည့် ၁၂ မိနစ်
The NYSE’s Future Buyer
Kalkine Media
Kalkine Media
·
ပြီးခဲ့သည့် ၁၉ မိနစ်
Why Is the S&P 500 Highlighting General Dynamics After Revenue Growth?
Seeking Alpha
Seeking Alpha
·
ပြီးခဲ့သည့် ၂ နာရီ
My Current View Of The S&P 500 Index: June 2026 Edition (Technical Analysis) (NYSEARCA:SPY)
About Withus Pharmaceutical Co Ltd
CEO-
Employees၂၂၃
Founded၂၀၀၄
Headquarters-
Sector-
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
Revenue
ဋေ ၂.၆၂ ထ
ဋေ ၂.၇၃ ထ
ဋေ ၂.၇၂ ထ
ဋေ ၂.၈၂ ထ
Cost of goods sold
၉၈၇.၉၅ ဋေ
၉၅၂.၉၆ ဋေ
၉၈၇.၅၉ ဋေ
၉၉၉.၆၅ ဋေ
Cost of revenue
၉၈၇.၉၅ ဋေ
၉၅၂.၉၆ ဋေ
၉၈၇.၅၉ ဋေ
၉၉၉.၆၅ ဋေ
Research and development expenses
-
-
၄၅.၂၂ ကုဋေ
၅၆.၅၁ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
ဋေ ၁.၅၅ ထ
ဋေ ၁.၆၃ ထ
ဋေ ၁.၅၀ ထ
ဋေ ၁.၆၈ ထ
Operating expense
ဋေ ၁.၅၅ ထ
ဋေ ၁.၆၃ ထ
ဋေ ၁.၅၉ ထ
ဋေ ၁.၈၀ ထ
Total operating expenses
ဋေ ၂.၅၄ ထ
ဋေ ၂.၅၉ ထ
ဋေ ၂.၅၈ ထ
ဋေ ၂.၈၀ ထ
Operating income
၈၃.၀၅ ကုဋေ
၁၃၇.၀၇ ဋေ
၁၃၈.၂၄ ဋေ
၂၄.၄၂ ကုဋေ
Other non operating income
၆၆.၂၄ ကုဋေ
၁၂၅.၈၉ ဋေ
-၁၀.၈၉ ကုဋေ
၁၁.၃၈ ကုဋေ
EBT including unusual items
၁၄၉.၂၉ ဋေ
၂၆၂.၈၂ ဋေ
-၁၅၆.၈၃ ဋေ
၇၁.၁၅ ကုဋေ
EBT excluding unusual items
၁၄၉.၂၉ ဋေ
၂၆၂.၈၂ ဋေ
၁၂၅.၈၇ ဋေ
၃၇.၀၂ ကုဋေ
Income tax expense
၁၉.၇၁ ကုဋေ
၄၈.၃၄ ကုဋေ
-၁၄၄.၈၀ ဋေ
-၃၂၆.၀၁ ဋေ
Effective tax rate
၁၃.၂၀%
၁၈.၃၉%
၉၂.၃၃%
-၄၅၈.၁၉%
Other operating expenses
-
-
၄.၀၈ ကုဋေ
၅.၃၄ ကုဋေ
Net income
၁၂၉.၅၉ ဋေ
၂၁၄.၄၉ ဋေ
-၁၂.၀၃ ကုဋေ
၃၉၇.၁၆ ဋေ
Net profit margin
၄.၉၄%
၇.၈၇%
-၀.၄၄%
၁၄.၀၈%
Earnings per share
-
-
-
-
Interest and investment income
-
-
၁၅.၁၉ ကုဋေ
၁၅.၅၀ ကုဋေ
Interest expense
-
-
-၁၆.၅၀ ကုဋေ
-၁၃.၈၃ ကုဋေ
Net interest expenses
-
-
-၁.၃၂ ကုဋေ
၁.၆၇ ကုဋေ
Depreciation and amortization charges
-
-
၉.၂၇ ကုဋေ
၁၄.၉၈ ကုဋေ
EBITDA
၁၈၃.၈၈ ဋေ
၂၄၀.၈၉ ဋေ
၂၄၂.၉၈ ဋေ
၁၃၂.၂၆ ဋေ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more